Clinical Trials

Showing trials with last updates posted in 2024.

NCT03338816 | COMPLETED | PHASE3
94 participants

ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-22
Start Date:
2017-11-16
Completion:
2019-01-31
Conditions
  • Acute Hepatic Porphyria
  • Acute Intermittent Porphyria
  • Porphyria, Acute Intermittent
  • Acute Porphyria
  • Hereditary Coproporphyria (HCP)
  • Variegate Porphyria (VP)
  • ALA Dehydratase Deficient Porphyria (ADP)
Interventions
  • DRUG
NCT03330561 | COMPLETED | PHASE1
85 participants

PRS-343 in HER2-Positive Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-22
Start Date:
2017-09-13
Completion:
2023-12-01
Conditions
  • HER2-positive Breast Cancer
  • HER2-positive Gastric Cancer
  • HER2-positive Bladder Cancer
  • HER2-positive Solid Tumor
Interventions
  • DRUG
No Results Yet
NCT02524405 | RECRUITING
345 participants

BEAM: Brain-Eye Amyloid Memory Study

Study Type:
OBSERVATIONAL
Last Updated:
2024-04-22
Start Date:
2016-02-29
Completion:
2025-03-31
Conditions
  • Alzheimer's Disease
  • Mild Cognitive Impairment
  • Vascular Cognitive Impairment
  • Parkinson's Disease
  • Lewy Body Disease
Interventions
  • OTHER
No Results Yet
NCT01960348 | COMPLETED | PHASE3
225 participants

APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis

Study Type:
INTERVENTIONAL
Last Updated:
2024-04-22
Start Date:
2013-11-30
Completion:
2017-08-31
Conditions
  • TTR-mediated Amyloidosis
  • Amyloidosis, Hereditary
  • Amyloid Neuropathies, Familial
  • Familial Amyloid Polyneuropathies
  • Amyloid Neuropathies
  • Amyloidosis, Hereditary, Transthyretin-Related
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page